The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection.

Authors

Mario A Flores-Valdez
César Pedroza-Roldán
Michel de Jesús Aceves-Sánchez
Eliza J R Peterson, Institute for Systems Biology, Seattle, WA, United States.
Nitin S Baliga, Institute for Systems Biology, Seattle, WA, United States.Follow
Rogelio Hernández-Pando
JoLynn Troudt
Elizabeth Creissen
Linda Izzo
Helle Bielefeldt-Ohmann
Thomas Bickett
Angelo A Izzo

Document Type

Article

Publication Date

1-1-2018

Publication Title

Front Microbiol

Keywords

BCG; biofilms; c-di-GMP; latent TB infection; pellicles; tuberculosis

Specialty

Institute for Systems Biology

Specialty

Pulmonary Medicine

Specialty

Infectious Diseases

Recommended Citation

Flores-Valdez, Mario A; Pedroza-Roldán, César; Aceves-Sánchez, Michel de Jesús; Peterson, Eliza J R; Baliga, Nitin S; Hernández-Pando, Rogelio; Troudt, JoLynn; Creissen, Elizabeth; Izzo, Linda; Bielefeldt-Ohmann, Helle; Bickett, Thomas; and Izzo, Angelo A, "The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection." (2018). Articles, Abstracts, and Reports. 169.
https://digitalcommons.providence.org/publications/169